We are live on
!
Find out more
GCM
Geneva Capital Management Portfolio holdings
AUM
$4.71B
1-Year Est. Return
6.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+6.32%
3 Year Est. Return
+44.91%
5 Year Est. Return
+59.73%
10 Year Est. Return
–
AUM
$6.14B
AUM Growth
+$280M
(+4.8%)
Cap. Flow
-$93.5M
Cap. Flow
% of AUM
-1.52%
Top 10 Holdings %
Top 10 Hldgs %
21.51%
Holding
129
New
1
Increased
12
Reduced
114
Closed
2
Top Buys
| 1 |
Onto Innovation
ONTO
|
+$16.3M |
| 2 |
ESCO Technologies
ESE
|
+$12M |
| 3 |
Ollie's Bargain Outlet
OLLI
|
+$11.4M |
| 4 |
Advanced Drainage Systems
WMS
|
+$10.2M |
| 5 |
QADA
QAD Inc.
QADA
|
+$8.51M |
Top Sells
| 1 |
Grand Canyon Education
LOPE
|
+$17.7M |
| 2 |
STAAR Surgical
STAA
|
+$14.9M |
| 3 |
Microchip Technology
MCHP
|
+$3.92M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$3.44M |
| 5 |
Tyler Technologies
TYL
|
+$3.17M |
Sector Composition
| 1 | Technology | 32.24% |
| 2 | Industrials | 22.15% |
| 3 | Healthcare | 21.8% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Financials | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fox Factory Holding Corp
FOXF
$819M
| $177M | 2.88% |
1,136,985
-19,091
| -2% | -$2.84M |
|
2
Bio-Techne
TECH
$11.2B
| $159M | 2.59% |
1,411,924
-21,772
| -2% | -$2.29M |
|
3
Fair Isaac
FICO
$28.8B
| $134M | 2.18% |
266,078
-3,793
| -1% | -$1.92M |
|
4
Omnicell
OMCL
$2.14B
| $132M | 2.16% |
874,634
-15,073
| -2% | -$2.1M |
|
5
BlackLine
BL
$1.78B
| $130M | 2.11% |
1,164,750
-27,245
| -2% | -$2.98M |
|
|
6
STAAR Surgical
STAA
$1.44B
| $125M | 2.04% |
821,717
-113,249
| -12% | -$14.9M |
|
7
Trex
TREX
$4.76B
| $124M | 2.02% |
1,212,704
-18,635
| -2% | -$1.88M |
|
8
Exponent
EXPO
$3.12B
| $114M | 1.86% |
1,279,299
-19,264
| -1% | -$1.8M |
|
|
9
Tyler Technologies
TYL
$13B
| $114M | 1.85% |
251,619
-7,452
| -3% | -$3.17M |
|
10
Kinsale Capital Group
KNSL
$7.74B
| $112M | 1.82% |
676,731
-10,955
| -2% | -$1.81M |
|
|
MASI
11
DELISTED
Masimo
MASI
| $108M | 1.76% |
444,832
-8,458
| -2% | -$1.93M |
|
|
LHCG
12
DELISTED
LHC Group LLC
LHCG
| $104M | 1.69% |
518,150
-6,736
| -1% | -$1.35M |
|
13
RBC Bearings
RBC
$18.4B
| $101M | 1.64% |
505,552
-7,931
| -2% | -$1.57M |
|
14
Alarm.com
ALRM
$2.68B
| $101M | 1.64% |
1,187,299
-17,776
| -1% | -$1.52M |
|
15
Globus Medical
GMED
$11B
| $97.4M | 1.59% |
1,256,526
-20,922
| -2% | -$1.49M |
|
16
Descartes Systems
DSGX
$6.5B
| $91.6M | 1.49% |
1,324,572
-23,765
| -2% | -$1.5M |
|
17
Bright Horizons
BFAM
$4B
| $89.6M | 1.46% |
609,287
-9,767
| -2% | -$1.46M |
|
|
BCPC
18
Balchem Corp
BCPC
$5.34B
| $87.9M | 1.43% |
669,325
-10,182
| -1% | -$1.31M |
|
19
SiteOne Landscape Supply
SITE
$4.78B
| $86.3M | 1.41% |
510,128
-8,582
| -2% | -$1.5M |
|
20
HealthEquity
HQY
$8.25B
| $85.2M | 1.39% |
1,058,532
-25,675
| -2% | -$1.96M |
|
21
EXL Service
EXLS
$4.38B
| $83.2M | 1.36% |
3,914,790
-49,265
| -1% | -$978K |
|
|
ENV
22
DELISTED
ENVESTNET, INC.
ENV
| $82.1M | 1.34% |
1,081,855
-14,384
| -1% | -$1.06M |
|
|
23
ESCO Technologies
ESE
$8.35B
| $80.2M | 1.31% |
854,664
+119,288
| +16% | +$12M |
|
24
Texas Roadhouse
TXRH
$13B
| $78M | 1.27% |
811,321
-13,524
| -2% | -$1.33M |
|
|
25
Ollie's Bargain Outlet
OLLI
$4.05B
| $78M | 1.27% |
927,089
+131,203
| +16% | +$11.4M |
|
Similar funds
AA
GCL
DCP
CCWM
KCM
BPCE
SCB
RS
Geneva Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geneva Capital Management held 129 positions worth $6.14B, up 4.8% from $5.86B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 2.3%. Geneva Capital Management opened 1 new position and exited 2, leaving the 129-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.
- Geneva Capital Management's largest Q2 2021 buy was Marvell Technology: 44,189 shares worth $2.58M.
- Geneva Capital Management added most to Onto Innovation in Q2 2021, an estimated $16.3M increase.
- Geneva Capital Management's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.9M.
- Geneva Capital Management fully exited Grand Canyon Education in Q2 2021, selling an estimated $17.7M.
- Geneva Capital Management's ten largest holdings make up 22% of its $6.14B portfolio in Q2 2021.
- Geneva Capital Management opened 1 new position and closed 2 in Q2 2021.
- Geneva Capital Management's portfolio value rose 4.8% quarter-over-quarter to $6.14B.
Based on Geneva Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.